Amyloid duration is associated with preclinical cognitive decline and tau PET
Rebecca L. Koscik, Tobey J. Betthauser, Erin McMullen Jonaitis, Samantha L. Allison, Lindsay R. Clark, Bruce P. Hermann, Karly Alex Cody, Jonathan W. Engle, Todd E. Barnhart, Charles K. Stone, Nathaniel A. Chin, Cynthia M. Carlsson, Sanjay Asthana, Bradley T. Christian, Sterling C. Johnson
This study uses longitudinal amyloid PET data to estimate amyloid chronicity and finds it is linked to cognitive decline and tau burden in preclinical Alzheimer's disease.
Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · Jan 1, 2020Peer-reviewedNeuroscience